Transcriptional regulation of podocyte disease

Translational Research

Volumn 149, Issue 5, 2007, Pages 237-242

  Chugh, Sumant S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KREISLER PROTEIN; LIM HOMEOBOX TRANSCRIPTION FACTOR 1 BETA; LIM PROTEIN; POD1 PROTEIN; PROTEIN DERIVATIVE; SMAD7 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX2; UNCLASSIFIED DRUG; WT1 PROTEIN; ZINC FINGER PROTEIN;

DISEASE COURSE; FOCAL GLOMERULOSCLEROSIS; GENETIC REGULATION; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; IN VIVO STUDY; NEPHROBLASTOMA; NONHUMAN; PODOCYTE; PODOCYTE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SEGMENTAL GLOMERULOSCLEROSIS; TRANSCRIPTION REGULATION;

EID: 34247361596     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.01.002     Document Type: Review

References (41)

1. Quaggin S.E. Transcriptional regulation of podocyte specification and differentiation. Microsc Res Tech 57 (2002) 208-211
2. Morello R., and Lee B. Insight into podocyte differentiation from the study of human genetic disease: nail-patella syndrome and transcriptional regulation in podocytes. Pediatr Res 51 (2002) 551-558
3. Hohenstein P., and Hastie N.D. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 15 (2006) R196-R201
4. Hammes A., Guo J.K., Lutsch G., Leheste J.R., Landrock D., Ziegler U., et al. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106 (2001) 319-329
5. Wagner N., Wagner K.D., Xing Y., Scholz H., and Schedl A. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1. J Am Soc Nephrol 15 (2004) 3044-3051
6. Barisoni L., Kriz W., Mundel P., and D′Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10 (1999) 51-61
7. Orloff M.S., Iyengar S.K., Winkler C.A., Goddard K.A., Dart R.A., Ahuja T.S., et al. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics 21 (2005) 212-221
8. Clement LC, Liu G, Kanwar YS, Avila-Casado C, Chugh SS. Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int. In press.
9. Palmer R.E., Kotsianti A., Cadman B., Boyd T., Gerald W., and Haber D.A. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr Biol 11 (2001) 1805-1809
10. Ryan G., Steele-Perkins V., Morris J.F., Rauscher III F.J., and Dressler G.R. Repression of Pax-2 by WT1 during normal kidney development. Development 121 (1995) 867-875
11. Pelletier J., Bruening W., Kashtan C.E., Mauer S.M., Manivel J.C., Striegel J.E., et al. Cell 67 (1991) 437-447
12. Barbaux S., Niaudet P., Gubler M.C., Grunfeld J.P., Jaubert F., Kuttenn F., et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17 (1997) 467-470
13. Discenza M.T., and Pelletier J. Insights into the physiological role of WT1 from studies of genetically modified mice. Physiol Genom 16 (2004) 287-300
14. Guo J.K., Menke A.L., Gubler M.C., Clarke A.R., Harrison D., Hammes A., et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 11 (2002) 651-659
15. Menke A.L., IJpenberg A., Fleming S., Ross A., Medine C.N., Patek C.E., et al. The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis. J Pathol 200 (2003) 667-674
16. Carpenter B., Hill K.J., Charalambous M., Wagner K.J., Lahiri D., James D.I., et al. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol Cell Biol 24 (2004) 537-549
17. Srichai M.B., Konieczkowski M., Padiyar A., Konieczkowski D.J., Mukherjee A., Hayden P.S., et al. A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus. J Biol Chem 279 (2004) 14398-14408
18. Dreyer S.D., Zhou G., Baldini A., Winterpacht A., Zabel B., Cole W., et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 19 (1998) 47-50
19. Chen H., Lun Y., Ovchinnikov D., Kokubo H., Oberg K.C., Pepicelli C.V., et al. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 19 (1998) 51-55
20. Vollrath D., Jaramillo-Babb V.L., Clough M.V., McIntosh I., Scott K.M., Lichter P.R., et al. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome. Hum Mol Genet 7 (1998) 1091-1098
21. Rohr C., Prestel J., Heidet L., Hosser H., Kriz W., Johnson R.L., et al. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 109 (2002) 1073-1082
22. Miner J.H., Morello R., Andrews K.L., Li C., Antignac C., Shaw A.S., et al. Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J Clin Invest 109 (2002) 1065-1072
23. Quaggin S.E., Schwartz L., Cui S., Igarashi P., Deimling J., Post M., et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 126 (1999) 5771-5783
24. Cui S., Li C., Ema M., Weinstein J., and Quaggin S.E. Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockout mice. J Am Soc Nephrol 16 (2005) 3247-3255
25. Dressler G.R., and Douglass E.C. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A 89 (1992) 1179-1183
26. Dehbi M., Ghahremani M., Lechner M., Dressler G., and Pelletier J. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene 13 (1996) 447-453
27. Wagner K.D., Wagner N., Guo J.K., Elger M., Dallman M.J., Bugeon L., et al. An inducible mouse model for PAX2-dependent glomerular disease: insights into a complex pathogenesis. Curr Biol 16 (2006) 793-800
28. Dressler G.R., Wilkinson J.E., Rothenpieler U.W., Patterson L.T., Williams-Simons L., and Westphal H. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362 (1993) 65-67
29. Yang Y., Gubler M.C., and Beaufils H. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron 91 (2002) 416-423
30. Dijkman H.B., Weening J.J., Smeets B., Verrijp K.C., van Kuppevelt T.H., Assmann K.K., et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 70 (2006) 338-344
31. Bariety J., Mandet C., Hill G.S., and Bruneval P. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 17 (2006) 2770-2780
32. Imaki J., Onodera H., Tsuchiya K., Imaki T., Mochizuki T., Mishima T., et al. Developmental expression of maf-1 messenger ribonucleic acids in rat kidney by in situ hybridization histochemistry. Biochem Biophys Res Commun 272 (2000) 777-782
33. Sadl V., Jin F., Yu J., Cui S., Holmyard D., Quaggin S., et al. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev Biol 249 (2002) 16-29
34. Fan Q., Shike T., Shigihara T., Tanimoto M., Gohda T., Makita Y., et al. Gene expression profile in diabetic KK/Ta mice. Kidney Int 64 (2003) 1978-1985
35. Schiffer M., Bitzer M., Roberts I.S., Kopp J.B., ten Dijke P., Mundel P., et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108 (2001) 807-816
36. Ross M.J., Martinka S., D′Agati V.D., and Bruggeman L.A. NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol 16 (2005) 2403-2411
37. Liu G., Clement L., Kanwar Y.S., Avila-Casado C., and Chugh S.S. ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome. J Biol Chem 281 (2006) 39681-39692
38. Chugh S., Yuan H., Topham P.S., Haydar S.A., Mittal V., Taylor G.A., et al. Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum. Kidney Int 59 (2001) 601-613
39. Glasser R.J., Velosa J.A., and Michael A.F. Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest 36 (1977) 519-526
40. Lim J., Hao T., Shaw C., Patel A.J., Szabo G., Rual J.F., et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125 (2006) 801-814
41. Bek M.J., Wahle S., Muller B., Benzing T., Huber T.B., Kretzler M., et al. Stra13, a prostaglandin E2-induced gene, regulates the cellular redox state of podocytes. FASEB J 17 (2003) 682-684